Skip to content
MedsAcross

Medicine

Cerebyx 500 mg/10 mL injection

Fosphenytoin · Intramuscular, intravenous · Pfizer Laboratories
Available on requestPrescription onlyUS FDA Cold chain

Cerebyx 500 mg/10 mL injection is a prescription medicine containing Fosphenytoin for intramuscular, intravenous use, marketed by Pfizer Laboratories, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians. It ships in a temperature-controlled cold chain.

Availability

Available on request

Export supply from India to licensed buyers

Typical lead time

On request

Counted from payment and complete documents

Shipping

Cold chain

Store under refrigeration at 2°C to 8°C (36°F to 46°F). The product should not…

Key facts

Active ingredient (INN)
Fosphenytoin
Brand
Cerebyx
Strength
500 mg/10 mL
Dosage form
Injection
Route
Intramuscular, intravenous
Packs
10 vials of 10 mL
Marketing authorisation holder
Pfizer Laboratories
Manufacturer
Pfizer Laboratories
Origin register
US FDA, United States
Storage
Store under refrigeration at 2°C to 8°C (36°F to 46°F). The product should not be stored at room temperature for more than 48 hours.
Cold chain
Yes, shipped temperature controlled
Prescription status
Prescription only
Controlled substance
Not recorded as controlled
ATC code
N03AB05 Fosphenytoin
HS code (indicative)
3004.90Indicative only. Your customs broker confirms the final tariff code.
Marketing category
marketed
Marketed since
28 October 2013
Identifiers
RxCUI 1670195, 1670197, 1670200 +1DailyMed set ID d4c36fad-0ba2-4cd4-9c5e-dcf843f38a5a, de5a6711-4abb-4c3d-a18b-266b094ace11NDC 0069-6001, 0069-5474Application NDA020450

Record updated 12 November 2026

Documents available

Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.

No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.

Packs

PackCodeLabelerMarketed since
10 vial, single-dose in 1 package / 10 mL in 1 vial, single-dose0069-5474-02Pfizer Laboratories28 October 2013
10 vial in 1 package / 10 mL in 1 vial0069-6001-21Pfizer Laboratories28 October 2013

Status by register

Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.

RegisterStatusSource
US FDAListed, marketedSource record for this pageChecked 12 November 2026
US FDAFirst approved 5 August 1996Drugs@FDA
EU (EMA)Not recorded—
India (CDSCO)Not yet confirmed against CDSCO approval lists—
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Import route

Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.

Import guides are available for 25 countries. Pick one to see its route summary.

BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides

Alternatives

Other makers and brands of Fosphenytoin 500 mg/10 mL injection.

Compare 1

Other strengths and forms of Fosphenytoin

Clinical summary

Fosphenytoin is an anti-epileptic agent indicated for the treatment of generalized tonic-clonic status epilepticus and prevention and treatment of seizures occurring during neurosurgery. It is available as injection for intramuscular and intravenous use. MedsAcross supplies Fosphenytoin for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Read about Fosphenytoin

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

Data sources

Need Cerebyx 500 mg/10 mL injection for your hospital or patient?

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.